ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

5,975Medicare Part D Prescriptions Filled, Including Refills

Rank: 32 out of 231

$338K Total Retail Price of All Prescriptions

Rank: 62 out of 231

226 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 226 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

9% of this provider’s 226 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 5,022 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
FUROSEMIDE 249 204 1 6
WARFARIN SODIUM 240 194 2 17
LISINOPRIL 191 165 3 1
SIMVASTATIN 167 144 4 2
AMLODIPINE BESYLATE 156 148 5 4
METOPROLOL TARTRATE 126 116 6 12
GABAPENTIN 124 84 7 15
HYDROCHLOROTHIAZIDE 109 91 8 9
POTASSIUM CHLORIDE 104 94 9 33
OMEPRAZOLE 100 75 10 5
SYNTHROID 98 96 11 28
ENDOCET 91 91 S2 12 49
SERTRALINE HCL 90 88 13 18
METOPROLOL SUCCINATE 89 68 14 13
INSULIN SYRINGE 85 44 15 43
METFORMIN HCL 82 76 16 7
MIRTAZAPINE 78 78 17 25
LEVOTHYROXINE SODIUM 76 60 18 3
HYDROCODONE-ACETAMINOPHEN 74 47 S3 19 21
ZOLPIDEM TARTRATE 73 70 20 14
TRAMADOL HCL 69 69 21 16
CARVEDILOL 66 50 22 24
CLOPIDOGREL 65 57 23 44
ATORVASTATIN CALCIUM 62 56 24 8
ALBUTEROL SULFATE 62 60 24 66
DONEPEZIL HCL 56 56 26 26
TAMSULOSIN HCL 56 56 26 30
PLAVIX 53 42 28 60
OLANZAPINE 52 52 29 65
NYSTATIN 52 30 29 87
SPIRIVA 52 45 29 61
ADVAIR DISKUS 52 49 29 50
AZITHROMYCIN 51 46 33 32
PREDNISONE 50 45 34 41
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 11, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.